Logo image
Molecular mechanisms of glycine transporter GlyT2 mutations in startle disease
Journal article   Open access   Peer reviewed

Molecular mechanisms of glycine transporter GlyT2 mutations in startle disease

V M James, J L Gill, M Topf and Robert J Harvey
Biological Chemistry, Vol.393(4), pp.283-289
2012
pdf
PDF - Published Version531.21 kBDownloadView
Published Version PDF - Published Version Open Access
url
https://doi.org/10.1515/BC-2011-232View
Published Version

Abstract

glycine transporters GlyR GlyT2 hyperekplexia startle disease
Startle disease affects newborn children and involves an exaggerated startle response and muscle hypertonia in response to acoustic or tactile stimuli. The primary cause of startle disease is defective inhibitory glycinergic transmission due to mutations in the postsynaptic glycine receptor (GlyR) α1 subunit gene (GLRA1). However, mutations have also been discovered in the genes encoding the GlyR β subunit (GLRB) and the presynaptic glycine transporter GlyT2 (SLC6A5). GlyT2 mutations have also been detected in Belgian Blue cattle and Irish Wolfhounds, where they have significant economic and animal welfare impacts. © 2012 by Walter de Gruyter . Berlin . Boston.

Details

Metrics

73 File views/ downloads
316 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Web Of Science research areas
Biochemistry & Molecular Biology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image